Chenguang Sui
Overview
Explore the profile of Chenguang Sui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan W, Sui C, Liu Q, Tang W, An H, Ma J
PLoS One
. 2014 Jul;
9(7):e102017.
PMID: 25019299
Metastasis is the main cause of mortality in patients with solid tumours. Identifying the exact molecules associated with CRC metastasis may be crucial to understand the process, which might also...
2.
Zhao C, Feng Q, Dou Z, Yuan W, Sui C, Zhang X, et al.
PLoS One
. 2013 Sep;
8(9):e73860.
PMID: 24040096
Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or...
3.
Yuan W, Xia G, Zhao C, Sui C, Ma J
Mol Med Rep
. 2011 Oct;
5(2):388-94.
PMID: 22020296
The activation of effector cells by bifunctional proteins to kill target cells has great potential in the treatment of cancer. In this study, a recombinant fusion protein composed of an...
4.
Guo H, Nan K, Hu T, Meng J, Hui W, Zhang X, et al.
Hepatol Res
. 2010 Oct;
40(11):1107-16.
PMID: 20880063
Aim: To investigate the unbalance of proliferation and apoptosis and the functions of cell-cycle proteins and apoptotic factor in metastasis of hepatocellular carcinoma (HCC) and their effect in prognosis. Methods: ...
5.
Sui C, Ma Q, Nan K, Xiao J, Suo A, Sha H, et al.
Oncol Rep
. 2009 Nov;
22(6):1391-6.
PMID: 19885591
Pancreatic cancer is generally refractory to most chemotherapeutic agents. We investigated whether hSSTR2 expression and octreotide treatment reverse multidrug resistance of human pancreatic cancer cells. We used pancreatic cancer cells...